Effects of gamma interferon and nitric oxide on the interaction of Mycobacterium avium subsp. paratuberculosis with bovine monocytes

Infection and Immunity

Volumn 65, Issue 5, 1997, Pages 1761-1766

  Zhao, Benyang ^a,b   Collins, Michael T ^a   Czuprynski, Charles J ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL VIRULENCE; CATTLE; CELL FREE SYSTEM; CELL KILLING; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE EXPRESSION; MYCOBACTERIUM AVIUM; NONHUMAN; PARATUBERCULOSIS; PHAGOCYTOSIS; PRIORITY JOURNAL; SPECIES DIFFERENTIATION; TISSUE INJURY;

EID: 0030939053     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.5.1761-1766.1997     Document Type: Article

References (50)

1. Adams, L. B., S. G. Franzblau, Z. Vavrin, J. B. J. Hibbs, and J. L. Krahenbuhl. 1991. L-Arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae. J. Immuno. 147:1642-1646.
2. Adler, H., B. Frech, M. Thony, H. Pfister, and T. W. Jungi. 1995. Inducible nitric oxide synthase in cattle - differential cytokine regulation of nitric oxide synthase in bovine and murine macrophages. J. Immunol. 154:4710-4718.
3. Albina, J. E. 1995. On the expression of nitric oxide synthase by human macrophages. Why no NO? J. Leukocyte Biol. 58:643-649.
4. Appelberg, R., and I. M. Orme. 1993. Effector mechanisms involved in cytokine-mediated bacteriostasis of Mycobacterium avium infections in murine macrophages. Immunology 80:352-359.
5. Britton, W. J., and N. Winter. 1994. Mechanisms of persistence of mycobacteria. Trends Microbiol. 2:284-288.
6. Chan, J., and S. H. E. Kaufmann. 1994. Immune mechanisms of protection, p. 389-416. In B. R. Bloom (ed.), Tuberculosis: Pathogenesis, Protection, and Control. ASM Press, Washington, D.C.
7. Chan, J., K. Tanaka, D. Carroll, J. Flynn, and B. R. Bloom. 1995. Effects of nitric oxide synthase inhibitors on murine infection With Mycobacterium tuberculosis. Infect. Immun. 63:736-740.
8. Chan, J., Y. Xing, R. S. Magliozzo, and B. R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-1122.
9. Chiodini, R. J., H. J. Van Kruiningen, and R. S. Merkal. 1984. Ruminant paratuberculosis (Johne's disease): the current status and future prospects. Cornell Vet. 74:217-262.
10. Chiodini, R. J., H. J. Van Kruiningen, W. R. Thayer, and J. A. Coutu. 1986. Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease. J. Clin. Microbiol. 24:357-363.
11. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178:2243-2247.
12. Cunha, F. Q., W. Y. Weiser, J. R. David, D. W. Moss, S. Moncada, and F. Y. Liew. 1993. Recombinant migration inhibitory factor induces nitric oxide synthase in murine macrophages. J. Immunol. 150:1908-1912.
13. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259:1739-1742.
14. Denis, M. 1991. interteron-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell. Immunol. 132:150-157.
15. Denis, M. 1994. Human monocytes/macrophages: NO or no NO? J. Leukocyte Biol. 55:682-684.
16. Douvas, G. S., D. L. Looker, A. E. Vatter, and A. J. Crowle. 1985. Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect. Immun. 50:1-8.
17. Fifis, T., L. A. Corner, J. S. Rothel, and P. R. Wood. 1994. Cellular and humoral immune responses of cattle to purified Mycobacterium bovis antigens. Scand. J. Immunol. 39:267-274.
18. Flesch, I., and S. H. Kaufmann. 1987. Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. J. Immunol. 138:4408-4413.
19. Flesch, I. E. A., and S. H. E. Kaufmann. 1991. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect. Immun. 59:3213-3218.
20. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
21. 15N]nitrate in biological fluids. Anal. Biochem. 126:131-138.
22. Hanano, R., and S. H. E. Kaufmann. 1995. Nitric oxide production and mycobacterial growth inhibition by murine alveolar macrophages: the sequence of rIFN-gamma stimulation and Mycobacterium bovis BCG infection determines macrophage activation. Immunol. Lett. 45:23-27.
23. Holland, S. M., E. M. Eisenstein, D. B. Kuhns, M. L. Turner, T. A. Fleisher, W. Strober, and J. I. Gallin. 1994. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N. Engl. J. Med. 330:1348-1355.
24. Jones, R. L. 1989. Review of the economic impact of Johne's disease in the United States, p. 46-50. In A. R. Milner and P. R. Wood (ed.), Johne's disease. Current trends in research, diagnosis and management. Commonwealth Scientific and Industrial Research Organisation, Melbourne, Australia.
25. Kamijo, R., J. Le, D. Shapiro, E. A. Havell, S. Huang, M. Aguet, M. Bosland, and J. Vilcek. 1993. Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J. Exp. Med. 178:1435-1440.
26. Kamijo, R., D. Shapiro, J. Le, S. Huang, M. Aguet, and J. Vilcek. 1993. Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor. Proc. Natl. Acad. Sci. USA 90:6626-6630.
27. Kaplan, G. 1994. Cytokine regulation of disease progression in leprosy and tuberculosis. Immunobiology 191:564-568.
28. kaplan, S. S., J. R. Lancaster, Jr., R. E. Basford, and R. L. Simmons. 1996. Effect of nitric oxide on staphylococcal killing and interactive effect with Superoxide. Infect. Immun. 64:69-76.
29. Kaufmann, S. H. E. 1993. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:129-163.
30. Lainbrecht, R. S., J. F. Carriere, and M. T. Collins. 1988. A model for analyzing growth kinetics of a slowly growing Mycobacterium sp. Appl. Environ. Mycrobiol. 54:910-916.
31. Lisby, G., J. Anderson, K. Engbaek, and V. Binder. 1994. Mycobacterium paratuberculosis in intestinal tissue from patients with Crohn's disease demonstrated by a nested primer polymerase chain reaction. Scand. J. Gastroenterol. 29:923-929.
32. Marletta, M. A. 1989. Nitric oxide: biosynthesis and biological significance. Trends Biochem. Sci. 14:488-492.
33. McDonough, K. A., Y. Kress, and B. R. Bloom. 1993. The interaction of Mycobacterium tuberculosis with macrophages: a study of phagolysosome fusion. Infect. Agents Dis. 2:232-235.
34. Mishina, D., P. Katsel, S. T. Brown, E. C. A. M. Gilberst, and R. J. Greenstein. 1996. On the etiology of Crohn disease. Proc. Natl. Acad. Sci. USA 93:9810-9820.
35. Molloy, A., and G. Kaplan. 1996. Cell mediated immune response, p. 305-314. In W. N. Rom and S. M. Garay (ed.), Tuberculosis. Little, Brown and Company. Boston, Mass.
36. Nakagawara, A., and C. F. Nathan. 1983. A simple method for counting adherent cells: application to cultured human monocytes, macrophages and multinuclear giant cells. J. Immunol. Methods 56:261-268.
37. Reiner, N. E. 1994. Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol. Today 15(8):374-381.
38. Riley, L. W. 1995. Determinants of cell entry and intracellular survival of Mycobacterium tuberculosis. Trends Microbiol. 3:27-31.
39. Riley, L. W. 1996. Phagocytosis of Mycobacterium tuberculosis, p. 281-289. In W. N. Rom and S. M. Garay (ed.), Tuberculosis. Little. Brown and Company, Boston, Mass.
40. Rook, G. A. W., J. Steel, M. Anisworth, and B. R. Champion. 1986. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology 59:333-338.
41. Salman, M. D., M. E. King, T. E. Wittum, C. R. Curis, K. G. Odde, and R. G. Mortimer. 1990. The National Animal Health Monitoring System in Colorado beef herds: disease rates and their associated costs. Prev. Vet. Med. 8:203-214.
42. Stuehr, D. J. 1992. Mammalian nitric oxide synthase. Adv. Enzymol. Relat. Areas Mol. Biol. 65:287-347.
43. Thompson, D. E. 1994. The role of mycobacteria in Crohn's disease. J. Med. Microbiol. 41:74-94.
44. Toba, H., J. T. Crawford, and J. J. Ellner. 1989. Pathogenicity of Mycobacterium avium for human monocytes: absence of macrophage-activating factor activity of gamma interferon. Infect. Immun. 57:239-244.
45. Yoo, H. S., M. S. Rutherford, S. K. Masheswaran, S. Shrinand, and T. R. Ames. 1996. Induction of nitric oxide production by bovine alveolar macrophages in response to Pasteurella haemolytica A1. Microb. Pathog. 20:361-375.
46. Zhao, B. Y., and M. T. Collins. Cellular and humoral immune response of cattle experimentally infected with Mycobacterium avium ss paratuberculosis. Submitted for publication.
47. Zhao, B. Y., M. T. Collins, and C. J. Czuprynski. 1996. Induction of L-arginine-dependent production of nitric oxide in bovine monocytes by interferon gamma and lipopolysaccharide. Res. Vet. Sci. 60:190-192.
48. Zhao, B. Y., C. J. Czuprynski, and M. T. Collins. Intracellular fate of Mycobacterium avium ss paratuberculosis in monocytes from uninfected and infected cows as determined by a radiometric method. Submitted for publication.
49. Zurbrick, B. G., and C. J. Czuprynski. 1987. Ingestion and intracellular growth of Mycobacterium paratuberculosis within bovine blood monocytes and monocyte-derived macrophages. Infect. Immun. 55:1588-1593.
50. Zurbrick, B. G., D. M. Follett, and C. J. Czuprynski. 1988. Cytokine regulation of the intracellular growth of Mycobacterium paratuberculosis in bovine monocytes. Infect. Immun. 56:1692-1697.